VRTX (VRTX)
US listed · Healthcare · Biotechnology
This page tracks VRTX (VRTX) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews VRTX against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Jul 1, 2026VRTX has staged a strong recovery from its late-January lows (~$429) to the current $496.73, closing near multi-week highs with an RSI of 73 confirming momentum, a bullish MACD histogram of +5.01, and positive news flow including a CNBC analyst recommendation and favorable coverage of its wide moat in CF and pipeline optionality. The composite pre-screen score of 2.01 is modest but directionally positive, supported by a low-beta defensive profile (0.29), reasonable P/E of 28.7x for a high-quality biotech, and 10.1% revenue growth.
No buy/sell call, target or confidence is shown: tracked against what stocks did next, they have not predicted direction.
VRTX — Frequently Asked Questions
Is VRTX (VRTX) a buy right now?
StockTracker AI does not rate VRTX a buy or a sell. As of July 1, 2026 its AI analysis sets out the evidence and the risks instead. Tracked against what stocks did next, its buy/sell calls have not predicted direction, so they are not shown. This is informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is the AI price forecast for VRTX?
StockTracker AI generates a probability-weighted 30-day price forecast for VRTX — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze VRTX?
Each scan screens VRTX on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for VRTX — free.
Add VRTX to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for VRTX
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →